|
|
 |
|
Viewing report
|
|
|
|
8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
Bioplan Associates Inc, April 2011, Pages: 492
The 2011 8th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production. This year's 8th Annual Report and Survey of Biopharmaceutical Manufacturing shows the industry has returned to robust growth. Based on analysis of 352 global biomanufacturers' 2011 budgets, expect substantial investment in new technologies that:
- Reduce costs and improve productivity
- Focus on novel downstream technologies
- Improve single-use device adoption rates
This year, among the 100s of significant findings: Budgets are growing in all areas measured, but the great majority are continuing to actively implement cost-cutting initiatives; a broad range of new products are being demanded from industry vendors to solve productivity problems, especially in single use and chromatography areas.
This report's 492 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more:
- Budget impact of current economic environment
- Downstream purification problems and issues
- Novel technologies
- Disposables analysis
- Current industry bottlenecks
- Capacity utilization and current production levels
- Current & Projected bottlenecks, 5-year trends
- Production trends and implications
- Outsourcing trends
- Expression system advances
- Range of titres
- Disposables: Spending, downstream, L&E's, trends & reasons; vendor satisfaction
- Batch failure rates & trends
- Selecting a CMO: Problems & solutions
- Quality management & PAT implementation
- Hiring and employment growth
- Supplier growth rates
- Training and management
Compare 352 biotherapeutic developers vs CMOs; US vs European & Global Biomanufacturing
Statistical information from this edition:
- Disposable bioreactors growing at 25% annually since 2005
- 53% are actively considering alternatives to protein A
- Budgets for new downstream technologies increasing 4%
- 73% of biomanufacturers are focusing on pro- ductivity; Fewer than half focusing on quality
- 38% demanding better disposable bags and connectors
- 74% ?nd better process control impacting productivity most
- 67.1%: Capacity Utilization Rate in Western Europe
- 56% demanding new downstream technologies to ease capacity constraints
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
